TRENTON, N.J. (AP) — A less-expensive version of the world’s top-selling insulin, Sanofi’s Lantus, could go on sale in the U.S. late next year. The French drugmaker said Monday it settled a lawsuit ...
Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71 st Scientific American Diabetes Association Sessions 2011, the results of three studies showing that people with diabetes using Sanofi ...
LAVAL, QC, Oct. 19 /CNW/ - Health Canada has approved the ClikSTAR reusable insulin pen for use with Lantus, giving patients with diabetes an additional option to safely and effectively achieve and ...
Sanofi has inaugurated a new assembling and packaging line to produce its flagship pre-filled insulin injection pen Lantus SoloSTAR at its Beijing plant located at the Beijing Economic-Technological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results